ClaimsFiler alerts Aevex investors to Oct. 20 lead plaintiff deadline
ClaimsFiler said investors who bought Aevex Class A stock during the stated period, or traced to the IPO documents, may seek lead plaintiff status by Oct. 20, 2026.
ClaimsFiler said investors in Aevex Corp. securities have until Oct. 20, 2026, to apply for lead plaintiff status in a class action pending in the U.S. District Court for the Southern District of California.
The case is captioned Rosenberg v. Aevex Corp., No. 26-cv-04779, according to the notice.
The alert said the case covers investors who purchased or otherwise acquired Aevex publicly traded Class A common stock between April 17, 2026, and June 4, 2026, inclusive, and those who bought shares pursuant to or traceable to the registration statement and prospectus used for Aevex's April 17, 2026 initial public offering.
According to the notice, Aevex trades on the New York Stock Exchange under the ticker AVEX. The suit alleges Aevex and certain executives concealed a pre-arranged plan involving Madison and underwriter defendants to override a 180-day lock-up after the IPO. The notice said Aevex had represented that the lock-up would prevent Madison from selling Class A common stock or converting or exchanging Class B shares or LLC units into Class A common stock for public sale until at least Oct. 13, 2026.
ClaimsFiler's alert also said the alleged plan would have cleared the way for a secondary public offering shortly after the IPO. The notice said Madison would have reaped more than $200 million and the underwriters would have shared more than $8 million in fees, according to the allegations in the lawsuit.
The source material did not include a response from Aevex, Madison or the underwriter defendants. It said ClaimsFiler provided a website and toll-free phone number for more information and said lawyers at Kahn Swick & Foti, LLC are available to discuss legal options.
The next deadline in the case is Oct. 20, 2026, for lead plaintiff applications noted in the alert.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()